Note 4 - Acquisitions (Details Textual) - Changzhou Eminence Biotechnology [Member] - USD ($) $ in Thousands |
Oct. 20, 2020 |
Oct. 02, 2020 |
Dec. 31, 2020 |
---|---|---|---|
Business Acquisition, Percentage of Voting Interests Acquired | 47.60% | ||
Business Combination, Consideration Transferred, Total | $ 9,800 | ||
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value | 9,000 | $ 8,985 | |
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount | 9,800 | ||
Developed Technology Rights [Member] | |||
Finite-Lived Intangible Asset, Useful Life (Year) | 13 years | ||
Customer Relationships [Member] | |||
Finite-Lived Intangible Asset, Useful Life (Year) | 10 years | ||
Minimum [Member] | |||
Variable Interest Entity, Financial or Other Support Expected Amount | 8,000 | ||
Maximum [Member] | |||
Variable Interest Entity, Financial or Other Support Expected Amount | $ 13,000 |
X | ||||||||||
- Definition Represents financial or other support expected amount for variable interest entity. No definition available.
|
X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Definition The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|